TECHNOLOGY DESCRIPTION
A breakthrough discovery using fungi, plant, or animal sources to produce anti-inflammatory and analgesic products to both treat and cure inflammatory disease includes a Provisional Patent application titled: Composition and Method of Producing Endogenous Therapeutic Anti Inflammatory Eicosanoids and their Metabolites by Exogenous or Oral Means.
The above invention teaches the use of cyclooxidase- 2 (COX-2) inhibitors which are the most useful products discovered to date for down regulating, or blocking the arthritic producing enzyme COX-2. Both Merck and Bristol-Myers (CelebrexT) and VioxxT introduced pharmaceutical COX-2 blockers in the late 1990's with enormous initial success. However due to the solvent nature of cyclic hydrocarbons on arterial plaques both products were removed from the market by the FDA in early 2001 and 2002 due to literally thousands of deaths due to fatal blood clots. The invention described above relies upon an entirely different and natural occurring hormone to reduce or block COX-2 induced inflammation.
Using the above citation as state of the "art" the two provisional patents are based on use of fungi to produce highly potent natural anti arthritics. Titled: Method and Process for Producing Metabolic Production from Fungi and Method and Process for Producing Lectin Products from Fungi the inventions synergistically incorporate two separate biological actions to treat and/or cure arthritic conditions.